BERTI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.793
EU - Europa 2.475
AS - Asia 524
AF - Africa 9
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.806
Nazione #
US - Stati Uniti d'America 3.784
PL - Polonia 1.029
IT - Italia 482
IE - Irlanda 362
SE - Svezia 307
HK - Hong Kong 149
CN - Cina 120
JO - Giordania 93
DE - Germania 66
RU - Federazione Russa 50
IN - India 42
KR - Corea 42
SG - Singapore 40
GB - Regno Unito 38
FI - Finlandia 34
CH - Svizzera 32
UA - Ucraina 27
VN - Vietnam 18
FR - Francia 13
TR - Turchia 12
CA - Canada 9
ES - Italia 9
TN - Tunisia 8
NL - Olanda 7
BE - Belgio 6
BR - Brasile 4
JP - Giappone 4
PT - Portogallo 4
GR - Grecia 3
IR - Iran 3
DK - Danimarca 2
RO - Romania 2
AT - Austria 1
EU - Europa 1
MK - Macedonia 1
MU - Mauritius 1
PH - Filippine 1
Totale 6.806
Città #
Warsaw 1.020
Fairfield 640
Ashburn 549
Chandler 368
Dublin 362
Woodbridge 278
Seattle 233
Cambridge 213
Houston 211
Wilmington 183
Altamura 134
Lawrence 129
Ann Arbor 113
Florence 105
Hong Kong 88
Princeton 82
Boston 57
Beijing 49
Buffalo 42
Moscow 42
Seoul 42
San Diego 41
Shanghai 36
Dearborn 35
Boardman 31
Medford 30
Bremen 29
Bern 28
Pune 28
New York 25
Jacksonville 24
Kent 24
Singapore 24
West Jordan 22
Hillsboro 15
Falls Church 14
Norwalk 14
Sesto Fiorentino 14
Dong Ket 12
Guangzhou 10
Izmir 10
Barcelona 9
Mateur 8
Scandicci 8
Toronto 8
Wroclaw 8
Brussels 6
London 6
Milan 6
Phoenix 6
Spoltore 6
Turin 6
Andover 5
Cagliari 5
Chennai 5
Fasano 5
Redwood City 5
Rome 5
Wuhan 5
Council Bluffs 4
Hefei 4
Lucca 4
Prato 4
Tappahannock 4
Washington 4
Wattenwil 4
Casamarciano 3
Misano Adriatico 3
Naples 3
Old Bridge 3
Salerno 3
San Mateo 3
Santa Maria A Monte 3
Siena 3
Viseu 3
Afragola 2
Albany 2
Bologna 2
Chicago 2
Corfu 2
Fiesole 2
Fontebuona 2
Fuzhou 2
Genoa 2
Grezzana 2
Hanover 2
Laurel 2
Monza 2
Nagold 2
Nanchang 2
Paris 2
Pisa 2
Poggibonsi 2
Redmond 2
Reggio Nell'emilia 2
Saint Paul 2
Sinalunga 2
Southwark 2
Vandoeuvre 2
Aalborg 1
Totale 5.622
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 269
Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction. 233
Bile leak after elective laparoscopic cholecystectomy: Role of MR imaging 228
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease 226
FDG PET and the genetics of dementia 220
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. 219
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 218
Neuroimaging studies in subjects at genetic risk of developing Alzheimer's disease: the role of neuroimaging to reveal the endophenotype 180
The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas 171
Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery 127
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 118
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 115
PET/CT in diagnosis of dementia. 114
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. 112
Clinical correlation of the binding potential with (123)I-FP-CIT in de novo idiopathic Parkinson's disease patients. 107
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. 101
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease 99
PET/CT in diagnosis of movement disorders. 97
Metastatic intracranial solitary fibrous tumors/hemangiopericytomas: description of two cases with radically different behaviors and review of the literature 96
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. 95
Biomarkers study in atypical dementia: proof of a diagnostic work-up 94
Primary Progressive Aphasia: Natural History in an Italian Cohort 93
Detection of infarct size safety threshold for left ventricular ejection fraction impairment in acute myocardial infarction successfully treated with primary percutaneous coronary intervention. 90
Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: Numerical and patient data evaluation 89
CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma 88
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 86
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 86
Back to the future: the absolute quantification of cerebral metabolic rate of glucose 85
Laparoscopic splenectomy as quaternary cytoreduction for isolated parenchymal splenic recurrence of epitelial tubo-ovarian cancer: Report of a case and literature review 84
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 84
Typical lung carcinoids: review of classification, radiological signs and nuclear imaging findings 83
Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease 80
Human Striatum Remodelling after Neurotransplantation in Huntington's Disease. 80
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 79
Characterization of functionally significant coronary artery disease by a coronary computed tomography angiography-based index: a comparison with positron emission tomography. 78
Structural brain changes in normal individuals with a maternal history of Alzheimer's 77
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 77
Nutrient patterns and brain biomarkers of Alzheimer’s disease in cognitively normal individuals 76
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 75
Electronic processing of digital panoramic radiography for the detection of apical periodontitis 75
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 75
Diagnostic imaging of typical lung carcinoids: relationship between MDCT, 111In-Octreoscan and 18F-FDG-PET imaging features with Ki-67 index 74
Sex differences in Alzheimer risk 73
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 73
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults 71
Reliability of myocardial perfusion gated SPECT for the reproducible evaluation of resting left ventricular functional parameters in long-term follow-up. 71
99mTc-EDDA/HYNIC-TOC is a new opportunity in Neuroendocrine Tumors of the Lung (and in other malignant and benign pulmonary diseases) 68
Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana 64
Early detection of Alzheimer's disease with PET imaging. 63
Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps 60
Evaluation of early dementia (Mild cognitive impairment) 59
Segmental quantitative myocardial perfusion with PET for the detection of significant coronary artery disease in patients with stable angina 58
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. 56
Alzheimer's disease: genetic basis and amyloid imaging as endophenotype 56
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 56
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 54
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 51
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 51
Brain : Normal Variations and Benign Findings in Fluorodeoxyglucose-PET/Computed Tomography Imaging 50
Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. 47
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 44
A tale of two tracers: Glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease 44
Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters 44
Anatomical remodelling of human striatum after neural transplantation in Huntington's disease 43
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 43
Amyloid PET in the diagnostic workup of neurodegenerative disease 43
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 43
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition 42
Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging 37
Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study 36
Molecular imaging and parkinson's disease 35
Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study 33
Sokoloff and Patlak methods for CMRGlu quantification with aortic image-derived input function: A feasibility study 33
Evaluation of age and sex-related metabolic changes in healthy subjects: An italian brain 18f-fdg pet study 32
The role of molecular imaging in the frame of the revised dementia with Lewy body criteria 31
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 30
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study 28
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 26
Brain metabolic connectivity reconfiguration in the semantic variant of primary progressive aphasia 26
Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques 25
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 24
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 24
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 23
Comprehensive qualitative characterization of linguistic performance profiles in primary progressive aphasia: a multivariate study with FDG-PET 22
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report 21
Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy 20
Diagnostic and therapeutic challenges in mast cell sarcoma 17
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 11
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 5
Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement 4
Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors 4
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 3
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 3
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 3
ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications 2
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 2
Applications of PET and SPECT in Patients with Autism Spectrum Disorder 2
The Association Between Positive Amyloid-PET and Cognitive Decline Is Not Always Supportive of Alzheimer’s Disease: Suggestions from a Case Report 1
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities 1
Totale 6.944
Categoria #
all - tutte 24.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.431 81 88 37 89 195 178 172 168 164 100 108 51
2020/2021848 70 87 80 111 57 62 44 71 72 110 38 46
2021/2022678 33 44 86 50 16 28 22 52 27 38 115 167
2022/20231.779 146 371 100 137 110 301 235 79 200 15 38 47
2023/20241.024 27 82 89 31 56 115 38 369 22 74 85 36
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 6.944